15 September 2025
GenIP Plc
("GenIP" or the "Company")
Strategic Partnership
GenIP Plc, a technology consultancy providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, has been appointed official technology transfer services provider to the Chile-based GreenTech Innovation Platform as part of its strategic partnership with the Universidad Autónoma de Chile.
The GreenTech Innovation Platform is used by over 400 members who have the potential to be GenIP clients, including universities, corporates, entrepreneurs, and public sector organisations, fostering collaboration to accelerate sustainable innovation in sectors such as commerce, services, and tourism.
The platform features tools for continuing education, events, talent recruitment, funding opportunities, and technological services, with a flagship program called InnovaSprint that provides $2,000,000 in funding for winning innovation projects.
As the platform's official technology transfer services provider, GenIP gains direct access to a high-quality pipeline of potential clients, offering its AI-powered evaluation, commercialisation, and talent-matching solutions to a growing regional innovation ecosystem.
Find out more about Universidad Autónoma de Chile here: https://www.uautonoma.cl/
Melissa Cruz, CEO of GenIP, commented:
"Being named the official technology transfer partner to such a well-connected innovation platform positions GenIP at the heart of a vibrant and expanding market in Latin America. This partnership provides direct access to over 400 potential clients and collaborators, supporting our strategy to drive growth through high-value global networks."
Daniela Fuentes Contreras, TTO Director at Universidad Autónoma de Chile, commented:
"Partnering with GenIP brings world-class expertise in technology evaluation, commercialisation, and talent connection to our GreenTech Innovation Platform. This collaboration will strengthen our capacity to help innovations from Chile and Latin America reach global markets, creating tangible benefits for our community and the region's economy."
For further information regarding GenIP, please visit www.genip.ai , or contact:
| GenIP Plc Melissa Cruz, CEO |
|
Via Redchurch Communications |
| |
|
|
| Novum Securities Limited (Broker) Jon Belliss |
|
Tel: +44 (0)20 7399 9425
|
| Redchurch Communications (Financial PR) John Casey
|
|
|
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
Notes to Editors
About GenIP
GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services.
GenIP provides two complementary services:
1. Invention Evaluator: Provides bespoke research reports that assess the market potential of new technological innovations and discoveries using AI-driven proprietary software; and
2. Vortechs: which is an executive recruitment service that uses advanced machine learning algorithms and natural language processing technologies to assist in matching technology organisations with experienced executives skilled in technology commercialisation.
The Company believes that its integrated GenAI service offerings will help organisations to evaluate and commercialise their technological innovations.
Company Strategy
GenIP's goal is to be a leading Generative AI analytic services company. To achieve this, the Company has established three strategic pillars:
· Organically grow Invention Evaluator and Vortechs' revenue through institutional and corporate connections as well as increase client pipeline through marketing, advertising and social media spend.
· Expand the Generative AI service offerings within Invention Evaluator and Vortechs' to reach new customers and improve margins.
· Bolt-on acquisitions of additional Generative AI services that are helpful to our clients and have demonstrated initial market traction.
Forward looking statements
Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.
Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".
For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.
-ENDS-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.